Trafalgar International (GCAN) Free Cash Flow (2017 - 2026)
Greater Cannabis Company (GCAN) posted quarterly Free Cash Flow of -$4376.0 for Q1 2026, up 60.77% year-over-year from -$2721.9 in Q1 2025, and up 81.87% quarter-over-quarter from -$24140.0 in Q4 2025.
Trafalgar International (GCAN) Free Cash Flow (2017 - 2026) Analysis & Trends
Greater Cannabis Company's Free Cash Flow history runs 10 years deep, the most recent figure standing at -$4376.0 for Q1 2026.
- In Q1 2026, Free Cash Flow rose 60.77% year-over-year to -$4376.0; the TTM figure through Mar 2026 stood at -$53374.0 (up 35.78% YoY), while the FY2025 annual figure was -$60153.0, up 45.06% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$4376.0, up from -$24140.0 in the prior quarter.
- The five-year high for Free Cash Flow was -$4376.0 in Q1 2026, with the low at -$56392.0 in Q2 2022.
- The 5-year median for Free Cash Flow is -$19064.0 (2022), against an average of -$22628.3.
- The sharpest annual moves came in 2024 and 2025: Free Cash Flow soared 84.96% in 2024, then tumbled 391.25% in 2025.
- Greater Cannabis Company's Free Cash Flow stood at -$19064.0 in 2022, then slumped by 71.39% to -$32673.0 in 2023, then jumped by 84.96% to -$4914.0 in 2024, then slumped by 391.25% to -$24140.0 in 2025, then surged by 81.87% to -$4376.0 in 2026.
- Business Quant data shows GCAN's Free Cash Flow at -$4376.0 in Q1 2026, -$24140.0 in Q4 2025, and -$5357.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Trafalgar International | 236,233.75 | 236,233.75 | - | -4,376.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,376.00 |
| Mar 31, 2026 | -4,376.00 |
| Dec 31, 2025 | -24,140.00 |
| Dec 31, 2025 | -24,140.00 |
| Sep 30, 2025 | -5,357.00 |
| Sep 30, 2025 | -5,357.00 |
| Jun 30, 2025 | -19,501.00 |
| Jun 30, 2025 | -19,501.00 |
| Mar 31, 2025 | -11,155.00 |
| Mar 31, 2025 | -11,155.00 |
| Dec 31, 2024 | -4,914.00 |
| Dec 31, 2024 | -4,914.00 |
| Sep 30, 2024 | -18,034.00 |
| Sep 30, 2024 | -18,034.00 |
| Jun 30, 2024 | -49,007.00 |
| Jun 30, 2024 | -49,007.00 |
| Mar 31, 2024 | -37,536.00 |
| Mar 31, 2024 | -37,536.00 |
| Dec 31, 2023 | -32,673.00 |
| Dec 31, 2023 | -32,673.00 |